Cargando…

Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats

BACKGROUND: Diabetic patients suffer from undesired intimal hyperplasia after angioplasty. Nicorandil has a trend to reduce the rate of target lesion revascularization. However, whether nicorandil inhibits intimal hyperplasia and the possible mechanisms underlying it remain to be determined. We aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying Qian, Tian, Feng, Zhou, Ying, Chen, Yun Dai, Li, Bo, Ma, Qiang, Zhang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826484/
https://www.ncbi.nlm.nih.gov/pubmed/27059601
http://dx.doi.org/10.1186/s12933-016-0377-6
_version_ 1782426338319138816
author Zhang, Ying Qian
Tian, Feng
Zhou, Ying
Chen, Yun Dai
Li, Bo
Ma, Qiang
Zhang, Ying
author_facet Zhang, Ying Qian
Tian, Feng
Zhou, Ying
Chen, Yun Dai
Li, Bo
Ma, Qiang
Zhang, Ying
author_sort Zhang, Ying Qian
collection PubMed
description BACKGROUND: Diabetic patients suffer from undesired intimal hyperplasia after angioplasty. Nicorandil has a trend to reduce the rate of target lesion revascularization. However, whether nicorandil inhibits intimal hyperplasia and the possible mechanisms underlying it remain to be determined. We aimed at assessing the effect of nicorandil on intimal hyperplasia in diabetic rats. METHODS: After intraperitoneal injection of streptozotocin (STZ, 50 mg/kg), balloon injury model was established in carotid arteries of diabetic rats. Rats were randomized to vehicle, nicorandil (15 mg/kg/day) or 5-hydroxydecanoate (5-HD, 10 mg/kg/day), a mitochondrial ATP-sensitive potassium channel (mitoK(ATP) channel)-selective antagonist. Perivascular delivery of εPKC siRNA was conducted to determine the role of εPKC pathway in intimal hyperplasia. In hyperglycemia environment (25 mM glucose), primary culture of vascular smooth muscle cells (VSMCs) were treated with nicorandil or 5-HD. Cell proliferation and cell migration were analyzed. RESULTS: Intimal hyperplasia significantly increased 14 days after balloon injury in diabetic rats (p < 0.01). Nicorandil inhibited intima development, reduced inflammation and prevented cell proliferation in balloon-injured arteries (p < 0.01). The protective effects of nicorandil were reversed by 5-HD (p < 0.05). εPKC was activated in balloon-injured arteries (p < 0.01). Nicorandil inhibited εPKC activation by opening mitoK(ATP) channel. Perivascular delivery of εPKC siRNA inhibited intimal hyperplasia, inflammation and cell proliferation (p < 0.01). High glucose-induced VSMCs proliferation and migration were inhibited by nicorandil. εPKC activation induced by high glucose was also inhibited by nicorandil and that is partially reversed by 5-HD. εPKC knockdown prevented VSMCs proliferation and migration (p < 0.01). CONCLUSIONS: Our study demonstrates that nicorandil inhibits intimal hyperplasia in balloon-injured arteries in diabetic rats. Nicorandil also prevents VSMCs proliferation and migration induced by high glucose. The beneficial effect of nicorandil is conducted via opening mitoK(ATP) channel and inhibiting εPKC activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0377-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4826484
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48264842016-04-10 Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats Zhang, Ying Qian Tian, Feng Zhou, Ying Chen, Yun Dai Li, Bo Ma, Qiang Zhang, Ying Cardiovasc Diabetol Original Investigation BACKGROUND: Diabetic patients suffer from undesired intimal hyperplasia after angioplasty. Nicorandil has a trend to reduce the rate of target lesion revascularization. However, whether nicorandil inhibits intimal hyperplasia and the possible mechanisms underlying it remain to be determined. We aimed at assessing the effect of nicorandil on intimal hyperplasia in diabetic rats. METHODS: After intraperitoneal injection of streptozotocin (STZ, 50 mg/kg), balloon injury model was established in carotid arteries of diabetic rats. Rats were randomized to vehicle, nicorandil (15 mg/kg/day) or 5-hydroxydecanoate (5-HD, 10 mg/kg/day), a mitochondrial ATP-sensitive potassium channel (mitoK(ATP) channel)-selective antagonist. Perivascular delivery of εPKC siRNA was conducted to determine the role of εPKC pathway in intimal hyperplasia. In hyperglycemia environment (25 mM glucose), primary culture of vascular smooth muscle cells (VSMCs) were treated with nicorandil or 5-HD. Cell proliferation and cell migration were analyzed. RESULTS: Intimal hyperplasia significantly increased 14 days after balloon injury in diabetic rats (p < 0.01). Nicorandil inhibited intima development, reduced inflammation and prevented cell proliferation in balloon-injured arteries (p < 0.01). The protective effects of nicorandil were reversed by 5-HD (p < 0.05). εPKC was activated in balloon-injured arteries (p < 0.01). Nicorandil inhibited εPKC activation by opening mitoK(ATP) channel. Perivascular delivery of εPKC siRNA inhibited intimal hyperplasia, inflammation and cell proliferation (p < 0.01). High glucose-induced VSMCs proliferation and migration were inhibited by nicorandil. εPKC activation induced by high glucose was also inhibited by nicorandil and that is partially reversed by 5-HD. εPKC knockdown prevented VSMCs proliferation and migration (p < 0.01). CONCLUSIONS: Our study demonstrates that nicorandil inhibits intimal hyperplasia in balloon-injured arteries in diabetic rats. Nicorandil also prevents VSMCs proliferation and migration induced by high glucose. The beneficial effect of nicorandil is conducted via opening mitoK(ATP) channel and inhibiting εPKC activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0377-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-08 /pmc/articles/PMC4826484/ /pubmed/27059601 http://dx.doi.org/10.1186/s12933-016-0377-6 Text en © Zhang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Zhang, Ying Qian
Tian, Feng
Zhou, Ying
Chen, Yun Dai
Li, Bo
Ma, Qiang
Zhang, Ying
Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
title Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
title_full Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
title_fullStr Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
title_full_unstemmed Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
title_short Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
title_sort nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826484/
https://www.ncbi.nlm.nih.gov/pubmed/27059601
http://dx.doi.org/10.1186/s12933-016-0377-6
work_keys_str_mv AT zhangyingqian nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats
AT tianfeng nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats
AT zhouying nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats
AT chenyundai nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats
AT libo nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats
AT maqiang nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats
AT zhangying nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats